A Critical Shift in Drug Development in the Post-Blockbuster World
Guests Thomas Krohn, Director, Clinical Open Innovation, Eli Lilly, Jerry Matczak, Community Manager for the Lilly Clinical Open Innovation Team, and Roland Andersson, Director for Accenture's Life Sciences R&D practice, discuss Lilly's Clinical Open Innovation project and the Transcelerate joint venture, both of which promote open source collaboration to speed development of new drugs.
Sorry we couldn't complete your registration. Please try again.
Please enter your email to finish creating your account.
Receive a personalized list of podcasts based on your preferences.